0001654954-17-005430.txt : 20170607 0001654954-17-005430.hdr.sgml : 20170607 20170607162328 ACCESSION NUMBER: 0001654954-17-005430 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170607 ITEM INFORMATION: Material Modifications to Rights of Security Holders FILED AS OF DATE: 20170607 DATE AS OF CHANGE: 20170607 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 17897470 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 8-K 1 cvm_8k.htm CURRENT REPORT Blueprint
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (date of earliest event reported): June 7, 2017
 
 
CEL-SCI CORPORATION
(Exact name of Registrant as specified in its charter)
 
 
 
Colorado
 
001-11889
 
84-0916344
(State or other jurisdiction
 
(Commission File No.)
 
(IRS Employer
of incorporation)
 
 
 
Identification No.)
 
 
8229 Boone Boulevard, Suite 802
Vienna, Virginia 22182
 (Address of principal executive offices, including Zip Code)
 
 
 
Registrant’s telephone number, including area code:  (703) 506-9460
 
 
N/A
(Former name or former address if changed since last report)
 

 

 
 
Item 3.03. Material Modification to Rights of Security Holders.
 
On June 7, 2017 the Company extended the expiration date of its Series DD warrants by one month from June 8, 2017 to July 10, 2017. The Series DD warrants were issued as part of a financing on December 8, 2016. The warrant exercise price of $0.18 as well as other terms of the warrant will remain unchanged.
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
Date: June 7, 2017
CEL-SCI CORPORATION
 
 
 
 
 
 
By:  
/s/  Patricia B. Prichep
 
 
 
Patricia B. Prichep
 
 
 
Senior Vice President of Operations